Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:31:28.445Z.
Calculation as of: 2026-10-06T21:31:28.445Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 273f4a35489c6dcba82bfbf6813c8f243fa8fa5e32baf23fc33ea9a1b57f5f97
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$179.26M
EV/FCF Ratio
N/A
TTM Avg
28.20x
3Y Avg
28.15x
5Y Avg
28.15x
Market Cap
$180.47M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
EV/FCF Ratio
N/A
TTM Avg
3.88x
3Y Avg
3.88x
5Y Avg
3.88x
Market Cap
$172.42M
EV/FCF Ratio
9.27x
TTM Avg
14.67x
3Y Avg
65.56x
5Y Avg
51.74x
Market Cap
$171.13M
EV/FCF Ratio
N/A
TTM Avg
277.79x
3Y Avg
277.79x
5Y Avg
277.79x
Market Cap
$189.11M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $179.75M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | N/A | 28.20x | 28.15x | 28.15x |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | N/A | 3.88x | 3.88x | 3.88x |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 9.27x | 14.67x | 65.56x | 51.74x |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 277.79x | 277.79x | 277.79x |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $169.53M | N/A | 72.04x | 55.57x | 55.57x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
